Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phase separation inhibitors and lens transparency

J I Clark1, J C Livesey, J E Steele

  • 1Department of Biological Structure, University of Washington, School of Medicine, Seattle.

Optometry and Vision Science : Official Publication of the American Academy of Optometry
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing the impact of coordinated COVID-19 exit strategies across Europe.

Science (New York, N.Y.)·2020
Same author

Overall survival by clinical risk category for high dose interleukin-2 (HD IL-2) treated patients with metastatic renal cell cancer (mRCC): data from the PROCLAIM<sup>SM</sup> registry.

Journal for immunotherapy of cancer·2019
Same author

Immune checkpoint inhibitors in advanced renal cell carcinoma: experience to date and future directions.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Factors at scene and in transfer related to the development of hypothermia in major burns.

Annals of burns and fire disasters·2017
Same author

Multidisciplinary treatment of olfactory neuroblastoma: Patterns of failure and management of recurrence.

American journal of otolaryngology·2015
Same author

Facial burns: acid drops.

British dental journal·2014
Same journal

Comparison of neutralization and disinfection kinetics in povidone iodine- and hydrogen peroxide-based soft contact lens care solutions.

Optometry and vision science : official publication of the American Academy of Optometry·2026
Same journal

Agreement between ganglion cell-inner plexiform layer metrics from widefield optical coherence tomography and Goldmann II, III, and V in glaucoma.

Optometry and vision science : official publication of the American Academy of Optometry·2026
Same journal

Repeatability of SpotChecks contrast sensitivity test in macular disease.

Optometry and vision science : official publication of the American Academy of Optometry·2026
Same journal

Reflections on emerging therapies for inherited retinal diseases following a community education event: A qualitative exploration.

Optometry and vision science : official publication of the American Academy of Optometry·2026
Same journal

Optical myopia control interventions: Evaluation of methods and success in a real-world population.

Optometry and vision science : official publication of the American Academy of Optometry·2026
Same journal

Influence of corneal endothelial cell density after penetrating keratoplasty on contact lens induced corneal swelling.

Optometry and vision science : official publication of the American Academy of Optometry·2026
See all related articles

A novel phase separation inhibitor, WR77913, shows potential in delaying or inhibiting lens opacification across various cataract models. Its efficacy varied depending on the cataract induction method and administration frequency.

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Biochemistry

Background:

  • Lens opacification, a key feature of cataracts, can result from diverse physiological and biochemical pathways.
  • Identifying therapeutic agents that can mitigate or prevent cataract formation is a significant challenge in ophthalmology.

Purpose of the Study:

  • To evaluate the efficacy of WR77913, a phase separation inhibitor, in preventing or delaying lens opacification in established animal models of cataract.
  • To determine if the effectiveness of WR77913 is dependent on the specific cataract model or administration regimen.

Main Methods:

  • WR77913 was administered via intraperitoneal injection to rats subjected to five different cataract induction models: radiation (RAD), selenite (SEL), galactose (GAL), streptozotocin (STZ), and Royal College of Surgeons (RCS).

Related Experiment Videos

  • Inhibition or delay of lens opacification was assessed following single or repeated administrations of WR77913 relative to cataract induction.

    • Main Results:

    • A single dose of WR77913 administered before induction effectively delayed or inhibited opacification in RAD, SEL, and STZ models.
    • Repeated administration of WR77913 was required to achieve similar inhibitory effects in the GAL and RCS cataract models.
    • These findings indicate that WR77913's efficacy is influenced by the underlying mechanism of cataractogenesis.

    Conclusions:

    • Phase separation inhibitors, exemplified by WR77913, demonstrate therapeutic potential for mitigating lens opacification.
    • The study suggests that WR77913 can be a promising agent for delaying or inhibiting cataract formation through various mechanisms.
    • Further research into optimizing WR77913 administration for different cataract types is warranted.